Abstract
Antimicrobial factors form one arm of the innate immune system, which protects mucosal surfaces from bacterial infection1,2,3. These factors can rapidly kill bacteria deposited on mucosal surfaces and prevent acute invasive infections1,2,3,4. In many chronic infections, however, bacteria live in biofilms, which are distinct, matrix-encased communities specialized for surface persistence5,6,7. The transition from a free-living, independent existence to a biofilm lifestyle can be devastating, because biofilms notoriously resist killing by host defence mechanisms and antibiotics5,8. We hypothesized that the innate immune system possesses specific activity to protect against biofilm infections. Here we show that lactoferrin, a ubiquitous and abundant constituent of human external secretions, blocks biofilm development by the opportunistic pathogen Pseudomonas aeruginosa. This occurs at lactoferrin concentrations below those that kill or prevent growth. By chelating iron, lactoferrin stimulates twitching, a specialized form of surface motility, causing the bacteria to wander across the surface instead of forming cell clusters and biofilms. These findings reveal a specific anti-biofilm defence mechanism acting at a critical juncture in biofilm development, the time bacteria stop roaming as individuals and aggregate into durable communities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Coonrod, J. D. The role of extracellular bactericidal factors in pulmonary host defenses. Semin. Respir. Infect. 1, 118–129 (1986)
Cole, A. M., Dewan, P. & Ganz, T. Innate antimicrobial activity of nasal secretions. Infect. Immun. 67, 3267–3275 (1999)
Ganz, T. Antimicrobial proteins and peptides in host defense. Semin. Respir. Infect. 16, 4–10 (2001)
Nizet, V. et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454–457 (2001)
Costerton, J. W., Stewart, P. S. & Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318–1322 (1999)
Hoiby, N. et al. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect. 3, 23–35 (2001)
Singh, P. K. et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762–764 (2000)
Xu, K. D., McFeters, G. A. & Stewart, P. S. Biofilm resistance to antimicrobial agents. Microbiology 146, 547–549 (2000)
Burns, J. L., Ramsey, B. W. & Smith, A. L. Clinical manifestations and treatment of pulmonary infections in cystic fibrosis. Adv. Pediatr. Infect. Dis. 8, 53–66 (1993)
Hoffmann, J. A., Kafatos, F. C., Janeway, C. A. & Ezekowitz, R. A. Phylogenetic perspectives in innate immunity. Science 284, 1313–1318 (1999)
Ward, C. G., Bullen, J. J. & Rogers, H. J. Iron and infection: new developments and their implications. J. Trauma 41, 356–364 (1996)
Abe, T., Nakajima, A., Matsunaga, M., Sakuragi, S. & Komatsu, M. Decreased tear lactoferrin concentration in patients with chronic hepatitis C. Br. J. Ophthalmol. 83, 684–687 (1999)
Harbitz, O., Jenssen, A. O. & Smidsrod, O. Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease. Eur. J. Respir. Dis. 65, 512–520 (1984)
Thompson, A. B., Bohling, T., Payvandi, F. & Rennard, S. I. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J. Lab. Clin. Med. 115, 148–158 (1990)
Hirai, Y. et al. Concentrations of lactoferrin and iron in human milk at different stages of lactation. J. Nutr. Sci. Vitaminol. (Tokyo) 36, 531–544 (1990)
Samson, R. R., Mirtle, C. & McClelland, D. B. Secretory IgA does not enhance the bacteriostatic effects of iron-binding or vitamin B12-binding proteins in human colostrum. Immunology 38, 367–373 (1979)
Sohnle, P. G., Collins-Lech, C. & Wiessner, J. H. The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. J. Infect. Dis. 164, 137–142 (1991)
Ellison, R. T. III The effects of lactoferrin on Gram-negative bacteria. Adv. Exp. Med. Biol. 357, 71–90 (1994)
Leitch, E. C. & Willcox, M. D. Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin. Curr. Eye Res. 19, 12–19 (1999)
Kolter, R. & Losick, R. One for all and all for one. Science 280, 226–227 (1998)
Tolker-Nielsen, T. et al. Development and dynamics of Pseudomonas sp. biofilms. J. Bacteriol. 182, 6482–6489 (2000)
Keberle, H. The biochemistry of deferrioxamine and its relation to iron metabolism. Ann. NY Acad. Sci. 119, 758–768 (1964)
Xiao, R. & Kisaalita, W. S. Iron acquisition from transferrin and lactoferrin by Pseudomonas aeruginosa pyoverdin. Microbiology 143, 2509–2515 (1997)
Martin, P. R., Watson, A. A., McCaul, T. F. & Mattick, J. S. Characterization of a five-gene cluster required for the biogenesis of type 4 fimbriae in Pseudomonas aeruginosa. Mol. Microbiol. 16, 497–508 (1995)
Britigan, B. E., Hayek, M. B., Doebbeling, B. N. & Fick, R. B. J. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect. Immun. 61, 5049–5055 (1993)
Stites, S. W., Plautz, M. W., Bailey, K., O'Brien-Ladner, A. R. & Wesselius, L. J. Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis. Am. J. Respir. Crit. Care Med. 160, 796–801 (1999)
Stites, S. W., Walters, B., O'Brien-Ladner, A. R., Bailey, K. & Wesselius, L. J. Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. Chest 114, 814–819 (1998)
Davies, D. G. et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280, 295–298 (1998)
Hentzer, M. et al. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol. 183, 5395–5401 (2001)
O'Toole, G. A. & Kolter, R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30, 295–304 (1998)
Acknowledgements
We thank E. Brutinel, T. Moninger and M. Neville for technical assistance, J. Kato of Hiroshima University for the twitching mutant, A. Berger for advice on data analysis, and our laboratory colleagues for discussions. This research was supported by the Howard Hughes Medical Institute, the National Heart, Lung and Blood Institute, the National Institute of General Medical Science, the Cystic Fibrosis Foundation, and the W. M. Keck Foundation Microbial Communities and Cell Signaling Laboratory. P.K.S. is the recipient of a NIH Mentored Physician Scientist Award, and a Cystic Fibrosis Foundation Leroy Matthews Award. M.J.W. is an Investigator of the Howard Hughes Medical Institute.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing financial interests.
Rights and permissions
About this article
Cite this article
Singh, P., Parsek, M., Greenberg, E. et al. A component of innate immunity prevents bacterial biofilm development. Nature 417, 552–555 (2002). https://doi.org/10.1038/417552a
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/417552a
This article is cited by
-
Increased Intestinal Permeability: An Avenue for the Development of Autoimmune Disease?
Exposure and Health (2024)
-
Proteomic analysis of sialoliths from calcified, lipid and mixed groups as a source of potential biomarkers of deposit formation in the salivary glands
Clinical Proteomics (2023)
-
Numerical investigation of mucociliary clearance using power law and thixotropic mucus layers under discrete and continuous cilia motion
Biomechanics and Modeling in Mechanobiology (2023)
-
Effect of Liposomal-Lactoferrin-Based Eye Drops on the Conjunctival Microflora of Patients Undergoing Cataract Surgery
Ophthalmology and Therapy (2023)
-
Influence of connatural factors in shaping vaginal microflora and ensuring its health
Archives of Gynecology and Obstetrics (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.